Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 33,418 shares at $93.80 ($3.1M) on 2021-07-27, disclosed to the SEC on 2021-07-29.
Open-market sale of $3.1M NBIX by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.80 | 16,709 | $1.6M | 50.0% |
| 2 | $93.80 | 16,709 | $1.6M | 50.0% |
| Total | $93.80 avg | 33,418 | $3.1M | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2022-02-09 | $544K | — | Filing → |
| NBIX | SELL | 2021-02-12 | $204K | — | Filing → |